Home › Funds › Distillate Capital Partners LLC › REGN

Distillate Capital Partners LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Distillate Capital Partners LLC reported holding 36,090 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$22.5M, representing 1.17% of its reported portfolio and ranking #22 among its reported holdings. Distillate Capital Partners LLC has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)36.09K sh
Reported value held$22.50M
Portfolio Weight1.17%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Distillate Capital Partners LLC's REGN position evolved

Distillate Capital Partners LLC first disclosed a stake in REGN in Q4 2024 at 32,141 shares (US$22.9M). Across 7 filings, Distillate Capital Partners LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 36,090 shares valued at US$22.5M — an increase of 7,520 shares quarter over quarter.. Notable position changes include a 33% increase in Q3 2025 (shares rose 36% over the following quarter), a 26% increase in Q2 2026 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 32.14K $22.89M New
Q1 2025 31.46K $19.96M Reduce
Q2 2025 27.98K $14.69M Reduce
Q3 2025 37.11K $20.88M Add
Q4 2025 28.38K $21.90M Reduce
Q1 2026 28.57K $22.07M Add
Q2 2026 36.09K $22.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Distillate Capital Partners LLC held REGN?

Distillate Capital Partners LLC has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Distillate Capital Partners LLC's current position in REGN?

As of Q2 2026, Distillate Capital Partners LLC holds 36.09K shares of REGN (REGENERON PHARMACEUTICALS), valued at $22.50M, representing 1.17% of its reported portfolio and ranking #22.

Has Distillate Capital Partners LLC been buying or selling REGN?

In the latest 13F filing (Q2 2026), Distillate Capital Partners LLC increased its position in REGN.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.